Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Recapitulation of developmental mechanisms to revascularize the ischemic heart
Karina N. Dubé, … , Paul R. Riley, Nicola Smart
Karina N. Dubé, … , Paul R. Riley, Nicola Smart
Published November 16, 2017
Citation Information: JCI Insight. 2017;2(22):e96800. https://doi.org/10.1172/jci.insight.96800.
View: Text | PDF
Research Article Cardiology

Recapitulation of developmental mechanisms to revascularize the ischemic heart

  • Text
  • PDF
Abstract

Restoring blood flow after myocardial infarction (MI) is essential for survival of existing and newly regenerated tissue. Endogenous vascular repair processes are deployed following injury but are poorly understood. We sought to determine whether developmental mechanisms of coronary vessel formation are intrinsically reactivated in the adult mouse after MI. Using pulse-chase genetic lineage tracing, we establish that de novo vessel formation constitutes a substantial component of the neovascular response, with apparent cellular contributions from the endocardium and coronary sinus. The adult heart reverts to its former hypertrabeculated state and repeats the process of compaction, which may facilitate endocardium-derived neovascularization. The capacity for angiogenic sprouting of the coronary sinus vein, the adult derivative of the sinus venosus, may also reflect its embryonic origin. The quiescent epicardium is reactivated and, while direct cellular contribution to new vessels is minimal, it supports the directional expansion of the neovessel network toward the infarcted myocardium. Thymosin β4, a peptide with roles in vascular development, was required for endocardial compaction, epicardial vessel expansion, and smooth muscle cell recruitment. Insight into pathways that regulate endogenous vascular repair, drawing on comparisons with development, may reveal novel targets for therapeutically enhancing neovascularization.

Authors

Karina N. Dubé, Tonia M. Thomas, Sonali Munshaw, Mala Rohling, Paul R. Riley, Nicola Smart

×

Figure 8

The epicardial lineage contributes pericytes, but not endothelial or smooth muscle cells, after myocardial infarction.

Options: View larger image (or click on image) Download as PowerPoint
The epicardial lineage contributes pericytes, but not endothelial or smo...
Wt1 lineage tracing (Wt1CreERT2/+; R26REYFP) with immunostaining revealed no contribution to PECAM1+ endothelial cells after infarction (A) but revealed extensive contribution of NG2+ pericytes by day 7 (B and C), some of which incorporated into infarct/border zone vessels by day 14 (D, enlarged in E). No contribution to αSMA+/SM-MHC+ smooth muscle cells was detected at any stage, shown at day 14, when nonlabeled smooth muscle was abundant in the epicardial vasculature (F, equivalent regions in I–N). EYFP-labeled epicardial cells (GFP+) migrate from the epicardium toward the infarct (F). Arterioles within the expanded epicardium express the venous marker Emcn, yet they are supported by SM-MHC+ cells (G, enlarged in H). Epicardial lineage cells (GFP+) do not contribute endothelial or smooth muscle cells (SM-MHC+; I, enlarged in J; same arterioles shown in G and H; αSMA+; K, enlarged in L; M, enlarged in N), although they closely associate with newly formed vessels (J, L, and N). Representative of n = 8 hearts at day 7 and n = 6 hearts at day 14. epi, epicardium; myo, myocardium. Scale bars: 50 μm (A–C, E, and M); 100 μm (D, F, G, I, and K); 20 μm (H, J, L, and N).

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts